Nav: Home

Stealth-cap technology for light-emitting nanoparticles

November 13, 2018

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the so-called "upconverting" nanoparticles that not only convert infrared light into UV-visible light, but also are water-soluble, remain stable in complex body fluids such as blood serum, and can be used to store medications. They have created a tool that could potentially make the fight against cancer significantly more effective. The researchers recently published their results in the journal Angewandte Chemie (DOI: 10.1002 / anie.201811003).

Nanoparticles are tiny structures, typically less than 100 nanometers in size, which is about 500 to 1000 times smaller than the thickness of a human hair. Such materials are receiving increasing attention for biomedical applications. If equipped with appropriate properties, they can reach almost any tissue in the human body via the bloodstream - turning into perfect body probes.

It has been known for some years that the distribution of nanoparticles in the body is essentially determined by their size and surface properties. Dr. Tanmaya Joshi at HZDR's Institute for Radiopharmaceutical Cancer Research says, "Upconverting nanomaterials are of great interest for biomedical imaging". "When stimulated with infrared light they can send out bright blue, green, or red signals. If we succeed in navigating such nano-probes to diseased tissues, it can be particularly useful for cancer diagnosis", the team's photochemist, Dr. Massimo Sgarzi, added.

However, these light upconverters show poor solubility in water or tissue fluids - a must to have feature before any diagnostic or therapeutic use could be imagined. For the HZDR team this was not a hindrance, but rather a challenge: "We used a unique polymer mixture to cover the particles," says Dr. Joshi, who joined HZDR in 2017 from Monash University, as a Humboldt Fellow. Adding this protective cover makes the light-transducing nanoparticles biocompatible. The biologist Dr. Kristof Zarschler adds: "The upconverters are now water-soluble and even have a neutral surface charge. Our research shows that this new cover can almost completely prevent the body's own substances (present in the blood serum) from binding to the particles. In other words, the nanoparticles now seem to wear an invisibility cloak. This, we believe, will help to avoid their recognition and elimination by phagocytes of the immune system. "

In order to keep the new nano-probes stable for weeks in a complex biological environment, the scientists photochemically link the components of the protective shell with each other: "We simply irradiated our nanoparticles with UV light. This creates additional bonds between the molecular components constituting the protective cover - much alike sewing together the individual parts of the cloak of invisibility with the help of light, "explains the PhD student, Anne Nsubuga. She further adds, "This shell is only a few nanometers thick, and may even be used for hiding other substances, for example, cancer drugs, which could be later on released in the tumour and destroy it."

Following this breakthrough, the team now intends to validate their current results in living organisms: "For this, we first have to carry out strictly regulated and ethically acceptable experiments on animals. Only when our stealth-cap technology works on these without any side effects, their medical potential will be explored in detail and their application on the patients can be considered", explains the group leader Dr. Holger Stephan cautiously.
-end-
Publication: Publikation: Anne Nsubuga, Kristof Zarschler, Massimo Sgarzi, Bim Graham, Holger Stephan, Tanmaya Joshi: „Towards Utilising Photocrosslinking of Polydiacetylenes (PDAs) for the Preparation of "Stealth" Upconverting Nanoparticles (UCNPs)", Angew. Chem. 2018, DOI: 10.1002/anie.201811003 (Link: https://doi.org/10.1002/anie.201811003 )

For more information:

Dr. Tanmaya Joshi
Institute of Radiopharmaceutical Cancer Research at HZDR
Phone +49 351 260 - 2437 | Email: t.joshi@hzdr.de">t.joshi@hzdr.de

Media contact:

Dr. Christine Bohnet | Head of HZDR Communications
Phone +49 351 260 - 2450 or +49 160 969 288 56 | Email: c.bohnet@hzdr.de">c.bohnet@hzdr.de
Helmholtz-Zentrum Dresden-Rossendorf (HZDR) | http://www.hzdr.de
Bautzner Landstr. 400 | 01328 Dresden | Germany

The Helmholtz-Zentrum Dresden-Rossendorf (HZDR) carries out research in the areas of Energy, Health and Matter. The following questions are key:

* How can energy and resources be utilized in an efficient, safe, and sustainable way?

* How can malignant tumors be more precisely visualized, characterized, and more effectively treated?

* How do matter and materials behave under the influence of strong fields and in smallest dimensions?

The HZDR operates large-scale infrastructures that are also available to external users, such as the Ion Beam Center (IBC), the Dresden High Magnetic Field Laboratory (HLD) and the Elbe Center for High-Power Radiation Sources.

HZDR is a member of the Helmholtz Association and has five sites (Dresden, Freiberg, Grenoble, Leipzig, Schenefeld near Hamburg) with almost 1,200 members of staff, of whom about 500 are scientists, including 150 Ph.D. candidates.

Helmholtz-Zentrum Dresden-Rossendorf

Related Nanoparticles Articles:

Nanoparticles: Acidic alert
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have synthesized nanoparticles that can be induced by a change in pH to release a deadly dose of ionized iron within cells.
3D reconstructions of individual nanoparticles
Want to find out how to design and build materials atom by atom?
Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.
Sweet nanoparticles trick kidney
Researchers engineer tiny particles with sugar molecules to prevent side effect in cancer therapy.
A megalibrary of nanoparticles
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles.
Dialing up the heat on nanoparticles
Rapid progress in the field of metallic nanotechnology is sparking a science revolution that is likely to impact all areas of society, according to professor of physics Ventsislav Valev and his team at the University of Bath in the UK.
Illuminating the world of nanoparticles
Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have developed a light-based device that can act as a biosensor, detecting biological substances in materials; for example, harmful pathogens in food samples.
What happens to gold nanoparticles in cells?
Gold nanoparticles, which are supposed to be stable in biological environments, can be degraded inside cells.
Lighting up cardiovascular problems using nanoparticles
A new nanoparticle innovation that detects unstable calcifications that can trigger heart attacks and strokes may allow doctors to pinpoint when plaque on the walls of blood vessels becomes dangerous.
Cutting nanoparticles down to size -- new study
A new technique in chemistry could pave the way for producing uniform nanoparticles for use in drug delivery systems.
More Nanoparticles News and Nanoparticles Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.